Rena Hirani Awarded the Inaugural James Isbister Prize at the Blood ISBT 2025
Rena Hirani, Senior Research Fellow at the Australian Red Cross Lifeblood, shared on LinkedIn:
”Following a big week of wins, I am thrilled to share yet more exciting news.
I was awarded the inaugural James Isbister Prize at the recent Blood ISBT 2025 Conference in Perth.
This honour marks a significant milestone in my research career, and I’m deeply grateful for the recognition.
Professor James Isbister is a pioneering figure in haematology, transfusion medicine and medical education.
His work shaped global standards in patient blood management.
Prof. Isbister completed his postgraduate training in internal medicine at St Vincent’s Hospital.
He was part of a team that performed the first successful Australian allogeneic bone marrow transplants, which is now commonly used to treat blood cancers.
Transfusion medicine became his passion since every speciality involves blood.
This prize, named after him in honour of his achievements to Australian medicine, was awarded for significant contributions in research into blood and blood products, education of the medical community and encouragement of appropriate clinical use of blood and plasma products for better healthcare.
The occasion was made even more memorable by the fact that James, energetically in his 80s, was present to award me personally which was a deeply meaningful honour.
I would also like to recognise the long term support of my work by Australian Red Cross Lifeblood, ANZSBT and National Blood Authority, Australia.
It is a true privilege to be a part of the transfusion community.”

More winner stories featured in Hemostasis Today.
-
Feb 23, 2026, 16:21Azin Alizadehasl: Introducing the Second Edition of a New Book on Echocardiography and Cardiac MRI
-
Feb 23, 2026, 16:16Kalyan Roy: When and Why Blood Irradiation Matters in Transfusion Medicine
-
Feb 23, 2026, 15:59Ney Carter Borges: Antithrombotic Therapy in 2025 – A Precision-Based Pharmacologic Update
-
Feb 23, 2026, 15:54Alan Nurden: From Early Discoveries to New Therapeutic Advances in von Willebrand Disease
-
Feb 23, 2026, 15:52Gevorg Tamamyan: Albania’s Vision for the Future of Pediatric Oncology
-
Feb 23, 2026, 15:36Simon Senanu: The Peripheral Blood Smear as an Essential Diagnostic Tool in Modern Medicine
-
Feb 23, 2026, 15:32Cheng-Hock Toh: The Paradox of Hematology
-
Feb 23, 2026, 15:20Rabab Al Dawood: Moderating the Coagulation and Hemostasis Session at the ISLH 1st Joint Conference
-
Feb 23, 2026, 15:16Amira Khater: Key Updates on Pulmonary Embolism Management from AHA and ACC Guidelines